ODRC researchers gathered for two energizing days of scientific talks, new insights and strengthened collaboration – covering everything from insulin resistance and T1D screening to islet biology and life‑course perspectives.

Oslo University Hospital is advertising a full-time Research Scientist / Postdoctoral position focusing on the viral aetiology of type 1 diabetes and other autoimmune diseases.

On World Diabetes Day, 14 November 2025, Professor Bjørn Olav Åsvold received the Diabetes Association’s Research Award for his outstanding contributions to diabetes research in Norway and internationally .

Sindre Lee-Ødegård has been awarded the Rising Award and Fellowship for 2025 by the European Association for the Study of Diabetes (EASD).

At the upcoming SSSD conference, Professor Knut Dahl-Jørgensen will receive the Novo Nordisk Foundation Nordic Diabetes Prize, among several other awards recognizing excellence in diabetes research. He will present a lecture titled “Virus as cause of type 1 diabetes.”.

Danish Diabetes and Endocrine Academy (DDEA) invites applications for a variety of funding opportunities, including PhD scholarships and postdoctoral fellowships, focusing on diabetes, metabolism, and endocrinology research.

Oslo University Hospital (OUS) has announced the recipients of its award for exceptional original articles published in the autumn of 2024. This honour includes a cash prize of 50,000 NOK for the winning research group, which can be utilized for unrestricted research purposes in 2025.

Jens Petter Berg, a Professor of Clinical Biochemistry and a member of the ODRC steering committee, has been elected as UiO’s Vice-Rector with a special responsibility for Life Sciences and Health.

Kjersti Skjold Rønningen passed away unexpectedly on Friday, March 21, 2025, at the age of 66. Lars Christian Stene has written this memorial tribute about her.

At the general ass embly of the Oslo Diabetes Research Center on March 20, 2025, held at the Green Auditorium, Ullevål Hospital, Lars Christian Mørch Stene was elected as the new leader of the centre.

The Dam Foundation, one of Norway's largest health-focused charities, is offering substantial funding for diabetes research through the Norwegian Diabetes Association. Researchers can apply for up to NOK 1,500,000 via the Dam Development program and up to NOK 3,000,000 through the Dam Research program.

Explore the inspiring journey and groundbreaking research of Knut Dahl-Jørgensen, who has dedicated over 20 years to uncovering viruses as a cause of type 1 diabetes.

A study, published in The Lancet Diabetes & Endocrinology in November 2024, presents findings from a longitudinal analysis of more than 100,000 children with type 1 diabetes, using data from eight national and one international pediatric diabetes registries. Covering the period from 2013 to 2022, the study focuses on changes in HbA1c levels, treatment regimens, and acute complications, highlighting the positive impact of advancements in diabetes technology.

Oslo Diabetes Research Centre is excited to announce that we are now open for applications for funding dedicated to providing time for researchers to work on applications for research funding. This program is designed to assist researchers in freeing up time from their regular work duties, allowing them to concentrate on preparing applications for significant external research grants.

Forekomsten av diabetes øker over hele verden, og 14. november markeres verdens diabetesdag. En ny studie i The Lancet Diabetes & Endocrinology, viser at antall nye tilfeller av både diabetes type 1 og type 2 blant unge voksne ikke går ned, og i mange land fortsetter å øke.

The Swedish Child Diabetes Foundation (Barndiabetesfonden), dedicated to supporting research aimed at preventing, curing, or alleviating diabetes in children and adolescents, has announced the opening of its 2025 research grant applications.

DD2 - Danish Centre for Strategic Research in type 2 diabetes has announced an upcoming research seminar. This seminar will guide attendees on how to leverage the unique DD2 cohort for their research and secure funding for their projects through the Novo Nordisk Foundation.

Noen mennesker får ikke bedret insulinfølsomhet av trening, til tross for økt VO2max og muskelstyrke. Serumproteomikk og maskinlæring kan brukes til å forutsi hvem dette gjelder, noe som på sikt kan gi bedre persontilpasset behandling.

En nylig publisert studie utforsker de molekylære effektene av en 12-ukers intervensjon med en kombinasjon av styrke- og utholdenhetstrening.

A new paper authored by Professor Knut Dahl-Jørgensen explores the potential link between viral infections and the onset of type 1 diabetes.